Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
29.31
-0.01 (-0.03%)
At close: Jun 20, 2025, 4:00 PM
29.40
+0.09 (0.31%)
After-hours: Jun 20, 2025, 7:24 PM EDT
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $3.53 billion as of June 20, 2025. Its market cap has increased by 33.36% in one year.
Market Cap
3.53B
Enterprise Value
2.16B
1-Year Change
33.36%
Ranking
Category
Stock Price
$29.31
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $3.53B, an increase of 250.67%. That is a compound annual growth rate of 28.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 3.53B | 1.83% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.63B |
| Johnson & Johnson | 361.13B |
| Novo Nordisk | 333.14B |
| AbbVie | 328.06B |
| UnitedHealth Group | 279.06B |
| Abbott Laboratories | 230.46B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |